BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 6398163)

  • 1. Prognostic significance of lymphocytic foci composition in minor salivary gland biopsies for severe disease flare and severity in Sjögren's syndrome: a 3-year follow-up cohort study.
    Park HS; Martínez-Martínez L; Magallares López B; Castellví I; Moya P; Codes-Mendez H; Hernandez Sosa N; Diaz-Torne C; Laiz A; Sainz L; Tandaipan JL; Mariscal A; Franco-Leyva T; Casademont J; Juarez C; Corominas H
    Front Immunol; 2024; 15():1332924. PubMed ID: 38469314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular B-cell clonality assay in minor salivary glands as a useful tool for the lymphoma risk assessment in Sjögren's syndrome.
    Benyamine A; Poulet A; Belenotti P; Nihous H; Ene N; Jarrot PA; Swiader L; Mancini J; Beaufils N; Essaydi A; Gabert J; Weiller PJ; Kaplanski G
    Joint Bone Spine; 2024 May; 91(3):105686. PubMed ID: 38161050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokines in Sjögren's syndrome.
    Roescher N; Tak PP; Illei GG
    Oral Dis; 2009 Nov; 15(8):519-26. PubMed ID: 19519622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is minor salivary gland biopsy still mandatory in Sjogren's syndrome? Does seronegative Sjogren's syndrome exist?
    Baldini C; Berardicurti O; Giacomelli R; Bombardieri M
    Autoimmun Rev; 2024 Jan; 23(1):103425. PubMed ID: 37634677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innate Immunity and Biological Therapies for the Treatment of Sjögren's Syndrome.
    Srivastava A; Makarenkova HP
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33271951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tubarial Salivary Glands in Sjogren Syndrome: Are They Just a Potential Missing Link With No Broader Implications?
    Mentis AA; Chrousos GP
    Front Immunol; 2021; 12():684490. PubMed ID: 34267754
    [No Abstract]   [Full Text] [Related]  

  • 7. Neutralizing antibodies against adeno-associated viruses in Sjögren's patients: implications for gene therapy.
    Corden A; Handelman B; Yin H; Cotrim A; Alevizos I; Chiorini JA
    Gene Ther; 2017 Apr; 24(4):241-244. PubMed ID: 28150697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deep sequencing of short RNAs reveals novel microRNAs in minor salivary glands of patients with Sjögren's syndrome.
    Tandon M; Gallo A; Jang SI; Illei GG; Alevizos I
    Oral Dis; 2012 Mar; 18(2):127-31. PubMed ID: 21895886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral biosciences: The annual review 2023.
    Ohshima H; Mishima K
    J Oral Biosci; 2024 Mar; 66(1):1-4. PubMed ID: 38309695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with ocular surface epithelial damage in patients with primary Sjögren's syndrome.
    Kim JE; Kim NR; Chin HS; Seo KY; Kim TI; Jung JW
    BMC Ophthalmol; 2021 Mar; 21(1):114. PubMed ID: 33653304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmunity at the ocular surface: pathogenesis and regulation.
    Stern ME; Schaumburg CS; Dana R; Calonge M; Niederkorn JY; Pflugfelder SC
    Mucosal Immunol; 2010 Sep; 3(5):425-42. PubMed ID: 20485329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnosis value of beta 2-microglobulin and immunoglobulins in primary Sjögren's syndrome.
    Maddali Bongi S; Campana G; D'Agata A; Palermo C; Bianucci G
    Clin Rheumatol; 1995 Mar; 14(2):151-6. PubMed ID: 7789054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epithelial HLA-DR expression and T lymphocyte subsets in salivary glands in Sjögren's syndrome.
    Lindahl G; Hedfors E; Klareskog L; Forsum U
    Clin Exp Immunol; 1985 Sep; 61(3):475-82. PubMed ID: 3907899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sialochemistry of patients with autoimmune rheumatic disease with and without histological manifestations of Sjögren's syndrome.
    Tsianos EB; Tzioufas AG; Mavridis AK; Sarras AK; Papadimitriou CS; Tsolas O; Moutsopoulos HM
    Ann Rheum Dis; 1985 Jun; 44(6):412-4. PubMed ID: 3874609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-DR expression by labial minor salivary gland tissues in Sjögren's syndrome.
    Moutsopoulos HM; Hooks JJ; Chan CC; Dalavanga YA; Skopouli FN; Detrick B
    Ann Rheum Dis; 1986 Aug; 45(8):677-83. PubMed ID: 3527087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet involvement in salivary gland inflammation in patients with primary Sjögren's syndrome.
    Oxholm P; Winther K
    Rheumatol Int; 1987; 7(1):29-33. PubMed ID: 2954201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary Sjögren's syndrome presenting as a case of sarcoidosis and a suspected pancreatic tumour.
    Koopmans PP; Bodeutsch C; de Wilde PC; Boerbooms AM
    Ann Rheum Dis; 1990 Jun; 49(6):407-9. PubMed ID: 2383067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of serum IgM kappa monoclonicity in patients with Sjögren's syndrome with an increased proportion of kappa positive plasma cells infiltrating the labial minor salivary glands.
    Moutsopoulos HM; Tzioufas AG; Bai MK; Papadopoulos NM; Papadimitriou CS
    Ann Rheum Dis; 1990 Nov; 49(11):929-31. PubMed ID: 2124096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presence of intracytoplasmic IgG in the lymphocytic infiltrates of the minor salivary glands of patients with primary Sjögren's syndrome.
    Lane HC; Callihan TR; Jaffe ES; Fauci AS; Moutsopoulos HM
    Clin Exp Rheumatol; 1983; 1(3):237-9. PubMed ID: 6398163
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.